Psychiatric Digital Biomarkers Market

The psychiatric digital biomarkers market consists of objective, quantifiable physiological and behavioral data collected through digital devices to assess mental health conditions. The primary customers include healthcare companies, pharmaceutical firms, and healthcare providers who use these tools for diagnosis, remote monitoring, and clinical trials. Key growth drivers are the rising prevalence of psychiatric disorders, significant advancements in AI and wearable sensor technology, and the increasing adoption of telemedicine.